Primary Record
rivastigmine
- In stock
- 8,047 g
- Purity
- 99.0 %
- CAS
- 123441-03-2
Compound Identifiers & Properties
- CAS
- 123441-03-2
- PubChem CID
- 77991
- SMILES
- CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
- Canonical SMILES
- CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1
Names & Synonyms
- rivastigmine
- Exelon
- Prometax
- 123441-03-2
- Nimvastid
- (S)-Rivastigmine
- Rivastigmine Teva
- Exelon Patch
- Rivastigmina
- ENA 713 free base
- rivastigmine hexal
- S-Rivastigmine
- rivastigminum
- Kerstipon
- Rivastach
- Somniton
- Erastig
- Alzest
- Eluden
- Voleze
- Rivastigmine tartrate
- Rivastigmine sandoz
- Rivastigmine base
- Prometax (TN)
- Rivastigmine.tartrate
- Exelon (TN)
- SDZ-ENA-713
- PKI06M3IW0
- Rivastigmine impurity D
- ENA-713
- Rivastigmine (Standard)
- Rivastigmine [USAN:INN]
- CHEMBL636
- RefChem:56914
- UNII-PKI06M3IW0
- Rivastigmine Transdermal System
- ENA-713D
- RIVASTIGMINE [MI]
- Rivastigmine Impurity 11
- C14H22N2O2
- RIVASTIGMINE [INN]
- RIVASTIGMINE [JAN]
- D0WY5Q
- Rivastigmine Hydrogen Tartrate
- SDZ ENA 713
- RIVASTIGMINE [USAN]
- ENA 713
- SCHEMBL2764
- CHEBI:8874
- RIVASTIGMINE [VANDF]
- RIVASTIGMINE 1 A PHARMA
- MFCD00871496
- DTXSID7023564
- RIVASTIGMINE [MART.]
- SDZ-212-713
- MLS003876822
- ONO-2540
- BIDD:GT0316
- RIVASTIGMINE [USP-RS]
- RIVASTIGMINE [WHO-DD]
- SDZ-ENA 713
- Rivastigmine (JAN/USP/INN)
- SDZ 212-713
- 713, SDZ ENA
- AC1L2U92
- DTXCID703564
- ENA 713, SDZ
- ENA713
- GTPL6602
- Hydrogen Tartrate, Rivastigmine
- orb1310812
- Tartrate, Rivastigmine Hydrogen
- ZINC4413
- RIVASTIGMINE [EMA EPAR]
- Rivastigmine (transdermal patch)
- SCHEMBL29614698
- SDZ-212713
- BDBM10620
- BDBM11682
- Rivastigmine [USAN:INN:BAN:JAN]
- AMY3808
- N06DA03
- XSVMFMHYUFZWBK-NSHDSACASA-N
- HMS2089H18
- HMS3715P15
- HMS3885B18
- RIVASTIGMINE [ORANGE BOOK]
- RIVASTIGMINE [EP MONOGRAPH]
- 713, ENA
- CID77991
- EBD46209
- MSK11179
- RIVASTIGMINE 3M HEALTH CARE LTD
- RIVASTIGMINE [USP MONOGRAPH]
- ABP001082
- EBC-08686
- HY-17368R
- (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate
- 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
- 3-(BENZYLOXY)-N-METHYLANILINE
- AKOS015896334
- C14-H22-N2-O2
- m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
- (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
- AC-8250
- ACN-034450
- AN-1074
- CCG-221197
- CS-0946
- DB00989
- FR15397
- Rivastigmine tartrate, 99% - 1G 1g
- RL06150
- KS-00000H18
- [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
- NCGC00167531-01
- NCGC00167531-03
- NCGC00167531-17
- AJ-08211
- AS-73448
- BC225687
- HY-17368
- SMR002203623
- SY115835
- AB1004572
- J982.502I
- LS-172571
- 2175B
- A3768
- NS00000463
- R0250
- S4687
- ST24049123
- Y9059
- C11766
- D03822
- D82061
- F10108
- W-5183
- 3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
- AB01275472-01
- AB01275472_02
- AB01275472_03
- Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
- EN300-7403044
- 101R548
- A805076
- F462714
- Q411887
- SR-05000001475
- I06-2037
- SR-05000001475-1
- SR-05000001475-2
- 3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate
- BRD-K10706131-046-02-8
- BRD-K10706131-046-03-6
- BRD-K10706131-046-04-4
- Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
- (S)-3-[1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
- 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate
- 3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate
- 415973-05-6
- Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
- [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methyl-carbamate
- B0084-082595
- (s)-n-ethyl-3-[(1-dimethylamino)ethyl]-n-methylphenylcarbamate
- 3-[1-(Dimethylamino)ethyl]phenyl (S)-Ethyl(methyl)carbamate
- Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-
- ethylmethylcarbamic acid 3-[1-(dimethylamino)ethyl]phenyl ester
- (3-((1S)-1-dimethylaminoethyl)phenyl) N-ethyl-N-methylcarbamate
- (S)-N-ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate
- [3-[(1S)-1-dimethylaminoethyl]phenyl] N-ethyl-N-methylcarbamate
- 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate
- 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl N-methyl carbamate
- Ethyl-methyl-carbamic acid 3-(1-dimethylamino-ethyl)-phenyl ester
- Ethylmethylcarbamic acid 3-[(S)-1-(dimethylamino)ethyl]phenyl ester
- Methylethylcarbamic acid 3-[(S)-1-(dimethylamino)ethyl]phenyl ester
- (S)-1-(3-((ethyl(methyl)carbamoyl)oxy)phenyl)-N,N-dimethylethanamine
- Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
- Ethyl-methyl-carbamic acid 3-((R)-1-dimethylamino-ethyl)-phenyl ester
- Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester
- Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
- N-Ethyl-N-methylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
- N-Ethyl-N-methylcarbamic acid 3-[(S)-1-(dimethylamino)ethyl]phenyl ester
- 129101-54-8
- 2,3-dihydroxybutanedioic acid; 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
- 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate; Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
- 3-[(1R)-1-(Dimethylamino)ethyl]phenyl N-Ethyl-N-methylcarbamate Hydrogen Tartrate ((R)-Rivastigmine Hydrogen Tartrate)
- 3-[(1S)-1-(Dimethylamino)ethyl]phenyl ethyl(methyl)carbamate; Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester; Carbamic acid, ethylmethyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester (9CI); Carbamic acid, ethylmethyl-, 3-[1-(dimethylamino)ethyl]phenyl ester, (S)-; ENA 713 free base; Exelon; Prometax; Rivastach; S-Rivastigmine; SDZ 212-713; [3-[(1S)-1-(Dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
- Exelon; Rivastigmine hydrogen tartrate; 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate; Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester; 3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate; ethylmethyl-Carbami